<DOC>
	<DOCNO>NCT00767273</DOCNO>
	<brief_summary>To test ability new image technique monitor predict response pancreatic cancer radiation and/or chemotherapy .</brief_summary>
	<brief_title>Investigate Role Metabolic Imaging Predicting Tumor Response/Outcome After Pancreatic CA Tx</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>Adult patient ( &gt; 18 ) histologically confirm adenocarcinomas pancreas treatment plan consist definitive palliative radiation therapy and/or chemotherapy without surgery . Negative urine pregnancy test woman childbearing potential ( WOCBP ) . WOCBP must use adequate method contraception avoid pregnancy throughout study period . All patient evaluate uniform manner Stanford GI Combined Modality Tumor Board determine eligibility . 1 . Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement . 2 . Any concurrent malignancy nonmelanomaskin cancer , carcinomainsitu cervix . Patients previous malignancy without evidence disease &gt; 5 year allow enter trial . 3 . WOCBP pregnant breastfeeding . 4 . Inability sign write consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>